Related Experiment Video
Updated: Jul 2, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism
Edwin J C G van den Oord1, Po-Hsiu Kuo, Annette M Hartmann
1Center for Biomarker Research and Personalized Medicine, Medical College of Virginia, Virginia Commonwealth University, PO Box 980533, Richmond, VA 23298-0533, USA. ejvandenoord@vcu.edu
This study identified genetic markers in the MAMDC1 gene associated with neuroticism. While small, these findings highlight the potential of genome-wide association studies for discovering new pathways in psychiatric disorders.
Area of Science:
- Psychiatric Genetics
- Behavioral Genetics
- Molecular Psychiatry
Background:
- Neuroticism, a tendency toward negative affect, is linked to internalizing disorders like anxiety and depression.
- Neuroticism significantly contributes to the comorbidity observed between these psychiatric conditions.
Purpose of the Study:
- To identify common genetic variants influencing neuroticism.
- To advance understanding of psychiatric disorder comorbidity.
- To inform the development of novel therapeutic strategies.
Main Methods:
- A genome-wide association study (GWAS) analyzed over 420,000 genetic markers in 1227 US individuals.
- Promising markers underwent replication in a German sample of 1880 individuals.
- A stringent replication definition and significance threshold were employed to minimize false positives.
Main Results:
- Single-nucleotide polymorphisms (SNPs) within the MAMDC1 gene showed the most promising association with neuroticism.
- These SNPs demonstrated consistent effects and directionality across both GWAS and replication samples.
- Combined analyses revealed several significant SNPs, meeting the study's threshold for potential pathogenic relevance.
Conclusions:
- The identified MAMDC1 SNPs have small effect sizes, potentially limiting immediate clinical utility.
- This GWAS demonstrates the power of large-scale genetic studies to uncover novel pathogenic pathways.
- Future research may leverage these pathways to develop more potent biomarkers for psychiatric conditions.
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Single Nucleotide Polymorphisms-SNPs
Pharmacogenomics: Identification of New Drug Targets
